Toutes les études
RecrutementPharmacologie Humaine (Phase I) - Étude de BioéquivalenceInterventionnel

A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalence Study of Paracetamol Orodispersible Tablet 500 mg (Haleon) to assess Bioequivalence with Alvedon 500 mg Film-Coated Tablet (Haleon, Sweden) and Panadol 500 mg Film-Coated Tablet (Haleon, Australia) in Healthy Adult Subjects Under Fasting Conditions

This study looked at a new paracetamol tablet that dissolves in your mouth, called an 'orodispersible' tablet. It compared how quickly and effectively your body absorbed this new tablet versus two well-known standard paracetamol tablets (Alvedon and Panadol). The main goal was to see if the new dissolvable tablet worked in a similar way to the existing ones. This type of research, called a 'bioequivalence study,' helps ensure that a new form of a medicine delivers the same amount of the active ingredient into your bloodstream as an established one, meaning it should have the same effect. Researchers gave a single dose of each paracetamol type to healthy adult volunteers on different days to make this comparison.

En un coup d'œil

Statut
Recrutement
Phase
Pharmacologie Humaine (Phase I) - Étude de Bioéquivalence
Sponsor
Haleon CH SARL
Objectif d'inscription
54
Démarrer
10 déc. 2024

De quoi parle cette étude ?

Imagine you're trying a new type of paracetamol that just melts in your mouth without needing water. This study is all about making sure that new dissolvable tablet works just as well as the paracetamol tablets you might already be familiar with, like Panadol.

Researchers wanted to see if your body absorbs the new dissolvable paracetamol in the same way – meaning at a similar speed and in a similar amount – as it absorbs the regular, film-coated tablets. This is really important because if your body absorbs the medicine differently, it might not work as expected. So, this study ensures that the new dissolvable paracetamol delivers the same amount of pain relief as the standard tablets.

This kind of study is called a 'bioequivalence study.' It's a common and necessary step when a company wants to introduce a new form of an existing medicine. It helps ensure that while the new tablet might feel different to take, its medical effect on your body is just the same as the trusted versions.

Points clés

  • This study compared a new fast-dissolving paracetamol tablet with standard paracetamol tablets.
  • The goal was to make sure the new tablet works the same way in your body as established ones.
  • It involved healthy adult volunteers taking a single dose of each paracetamol type.
  • Blood samples were taken to see how the paracetamol was absorbed.
  • Known as a 'bioequivalence study,' it's a standard step for new medicine formats.

Qui peut être éligible ?

This study was looking for healthy adults to take part. This means people who don't have any ongoing health problems that could affect how their body handles medicines.

Participants needed to be at least 18 years old. There wasn't an upper age limit mentioned, so older adults could also be considered if they were otherwise healthy.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Are you generally healthy with no ongoing medical conditions?
  2. Avez-vous 18 ans ou plus ?
  3. Are you able to attend clinic visits for blood draws?
  4. Are you comfortable taking a single dose of paracetamol?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you had taken part in this study, you would have received a single dose of one type of paracetamol on a specific day, then a different type on another day, and finally the third type on a third day. These days would have been separated by a break to allow the previous dose to leave your system.

On each study day, you would have had blood samples taken regularly over several hours after taking the medicine. This helps researchers measure how much paracetamol is in your bloodstream over time. You would also have had some general health checks to make sure you remained well throughout the study. The total duration of your involvement, including all visits and follow-ups, would have been explained in detail.

Risques et avantages potentiels

The main benefit of taking part in a study like this is contributing to medical science and helping to make sure new medicines are safe and effective for everyone. You might also receive some compensation for your time and travel. Potential risks are usually small, especially in studies involving well-known medicines like paracetamol in healthy people. You might experience minor discomfort from blood draws, or very rarely, side effects from paracetamol, though it was given at a standard dose. You would always have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Emplacements (1)

Certains emplacements de site sont approximatifs. Nous améliorons cela — veuillez vérifier avec l'équipe d'essai avant de vous déplacer.
  • —
    Non vérifié
    Allemagne

Questions fréquentes

What is 'paracetamol'?

Paracetamol is a common medicine used to relieve pain and reduce fever. You might know it as Panadol or by its generic name.

Que signifie 'bioéquivalence' ?

It means researchers are checking if a new version of a medicine works in your body in the exact same way as an existing, trusted version. It's about ensuring consistency.

What is an 'orodispersible tablet'?

This is a type of tablet that dissolves quickly in your mouth, usually without needing any water to swallow it. It's often helpful for people who have difficulty swallowing pills.

Why do studies like this use 'healthy volunteers'?

Using healthy volunteers helps researchers understand how the medicine behaves in the body without other health conditions interfering. This makes the results clearer.

Will this new paracetamol be better than regular tablets?

The aim of this study is not to make it 'better' but to confirm it's 'the same' in terms of how your body uses it. The main difference would be how easy it is to take.

Comment en savoir plus

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "A Phase I, Randomised, Open Label, Single Center, Single Ora… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.